Xu Lili, Wan Yongxian, Huang Juan, Xu Fangyuan
Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, PR China.
Department of Bone and Joint Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, PR China.
J Cancer Res Ther. 2018 Jan;14(1):99-102. doi: 10.4103/jcrt.JCRT_736_17.
The objective of this study is to investigate the clinical efficacy and safety of electroacupuncture and multiple acupoint stimulation in relieving cancer pain in patients with advanced hepatocellular carcinoma.
Sixty-five cases of advanced hepatocellular carcinoma with cancer pain were selected in our hospital and were divided into electroacupuncture multiple acupoint stimulation group (electroacupuncture group) (n = 32) and fentanyl transdermal patch analgesia group (control group) (n = 33) according to analgesic methods and intentions. In the electroacupuncture group, electric acupuncture treatment was administered at different acupoints, including Baihui, Quchi, Neiguan, Xuehai, Zusanli, and Sanyinjiao acupoint, once a day for 7 days. In the control group, a fentanyl transdermal patch was placed on the upper left arm every 3 days and replaced with a continuous external paste once for 7 days. Pain scores in the two groups before and during the treatment were evaluated with a visual analog scale (VAS), and adverse reactions during the treatment were recorded.
The VAS pain score of the electroacupuncture group was significantly decreased on day 3 (P < 0.05), but the pain scores were not significantly different (P > 0.05) between the two groups 4 days after treatment. For treatment-related side effects, there were 3 cases of subcutaneous hemorrhage in the electroacupuncture group; 1 case of skin rashes and 3 cases of nausea and vomiting in the control group. The incidences of adverse reactions in the two groups were 9.4% and 12.1%, respectively, without significant difference (P > 0.05).
Cancer pain in patients with advanced hepatocellular carcinoma can be alleviated with electroacupuncture and multiple acupoint stimulation, but the onset pain relief was slow. To improve the analgesic effects of this technique, the combination of various analgesic methods should be necessary in early stage of the treatment.
本研究旨在探讨电针及多穴位刺激缓解晚期肝细胞癌患者癌痛的临床疗效及安全性。
选取我院65例伴有癌痛的晚期肝细胞癌患者,根据镇痛方法及意愿分为电针多穴位刺激组(电针组)(n = 32)和芬太尼透皮贴剂镇痛组(对照组)(n = 33)。电针组于百会、曲池、内关、血海、足三里、三阴交等不同穴位行电针治疗,每日1次,共7天。对照组每3天于左上臂贴敷芬太尼透皮贴剂,持续外用1次,共7天。采用视觉模拟评分法(VAS)评估两组治疗前及治疗期间的疼痛评分,并记录治疗期间的不良反应。
电针组第3天VAS疼痛评分显著降低(P < 0.05),但治疗4天后两组疼痛评分差异无统计学意义(P > 0.05)。治疗相关不良反应方面,电针组有3例皮下出血;对照组有1例皮疹、3例恶心呕吐。两组不良反应发生率分别为9.4%和12.1%,差异无统计学意义(P > 0.05)。
电针及多穴位刺激可缓解晚期肝细胞癌患者的癌痛,但起效较慢。为提高该技术的镇痛效果,治疗早期应联合多种镇痛方法。